Excess mortality and morbidity, functioning and health status after high dose chemotherapy with autologous stem cell support - a national follow-up study. Part 1.
- Prosjektnummer
- 2011098
- Ansvarlig person
- Stein Kvaløy
- Institusjon
- Oslo universitetssykehus HF
- Prosjektkategori
- Postdoktorstipend
- Helsekategori
- Cancer
- Forskningsaktivitet
- 7. Disease Management
Nei
Nei
Nei
Sexual function in long-term male lymphoma survivors after high-dose therapy with autologous stem-cell transplantation.
Bone Marrow Transplant 2020 05;55(5):891-905. Epub 2019 nov 19
PMID: 31745250
Survivors' knowledge of their diagnosis, treatment and possible late adverse effects after autologous stem cell transplantation for lymphoma.
Acta Oncol 2019 Sep;58(9):1315-1322. Epub 2019 jul 9
PMID: 31286808
Lifestyle behavior among lymphoma survivors after high-dose therapy with autologous hematopoietic stem cell transplantation, assessed by patient-reported outcomes.
Acta Oncol 2019 May;58(5):690-699. Epub 2019 jan 30
PMID: 30696346
Chronic fatigue is highly prevalent in survivors of autologous stem cell transplantation and associated with IL-6, neuroticism, cardiorespiratory fitness, and obesity.
Bone Marrow Transplant 2019 04;54(4):607-610. Epub 2018 sep 27
PMID: 30262906
Obstructive and restrictive pulmonary dysfunction in long-term lymphoma survivors after high-dose therapy with autologous stem cell transplantation.
Acta Oncol 2018 Jun;57(6):773-781. Epub 2017 nov 24
PMID: 29171324
Bone mineral density is close to normal for age in long-term lymphoma survivors treated with high-dose therapy with autologous stem cell transplantation.
Acta Oncol 2017 Apr;56(4):590-598. Epub 2017 jan 12
PMID: 28077016
Diffusing capacity impairment is prevalent in long-term lymphoma survivors after high-dose therapy with autologous stem cell transplantation.
Bone Marrow Transplant 2017 04;52(4):646-649. Epub 2016 des 19
PMID: 27991891
Pattern of employment and associated factors in long-term lymphoma survivors 10 years after high-dose chemotherapy with autologous stem cell transplantation.
Acta Oncol 2016 May;55(5):547-53.
PMID: 27123741
Impaired Right Ventricular Function in Long-Term Lymphoma Survivors.
J Am Soc Echocardiogr 2016 Jun;29(6):528-36. Epub 2016 mar 30
PMID: 27038515
Cardiorespiratory fitness in long-term lymphoma survivors after high-dose chemotherapy with autologous stem cell transplantation.
Br J Cancer 2016 Jul 12;115(2):178-87. Epub 2016 jun 28
PMID: 27351215
A national study on conditional survival, excess mortality and second cancer after high dose therapy with autologous stem cell transplantation for non-Hodgkin lymphoma.
Br J Haematol 2016 May;173(3):432-43. Epub 2016 feb 23
PMID: 26914167
Valvular Dysfunction in Lymphoma Survivors Treated With Autologous Stem Cell Transplantation: A National Cross-Sectional Study.
JACC Cardiovasc Imaging 2016 Mar;9(3):230-9. Epub 2016 feb 17
PMID: 26897666
Heart Failure and Asymptomatic Left Ventricular Systolic Dysfunction in Lymphoma Survivors Treated With Autologous Stem-Cell Transplantation: A National Cross-Sectional Study.
J Clin Oncol 2015 Aug 20;33(24):2683-91. Epub 2015 jul 13
PMID: 26169610
Conditional survival and excess mortality after high-dose therapy with autologous stem cell transplantation for adult refractory or relapsed Hodgkin lymphoma in Norway.
Haematologica 2015 Jun;100(6):e240-3. Epub 2015 feb 14
PMID: 25682605
High-dose therapy with autologous stem cell support for lymphoma--from experimental to standard treatment.
Tidsskr Nor Laegeforen 2013 Sep 3;133(16):1735-9.
PMID: 24005713
High-dose therapy with autologous stem cell support for lymphoma in Norway 1987-2008.
Tidsskr Nor Laegeforen 2013 Sep 3;133(16):1704-9.
PMID: 24005706
Cardiovascular status in long term survivors of lymphomas and malignant ovarian germ cell tumors
- Disputert:
- februar 2017
- Hovedveileder:
- Svend Aakhus
- Trine Bjøro Prosjektdeltaker
- Alexander Fosså Prosjektdeltaker
- Kjersti Helene Hernæs Prosjektdeltaker
- Jo Steinson Stenehjem Prosjektdeltaker
- Øystein Fluge Prosjektdeltaker
- Hanne Bersvendsen Prosjektdeltaker
- Unn Merete Fagerli Prosjektdeltaker
- Svend Aakhus Prosjektdeltaker
- Klaus Murbræch Doktorgradsstipendiat (annen finansiering)
- Harald Holte Prosjektdeltaker
- Knut Halvor Bjøro Smeland Doktorgradsstipendiat (annen finansiering)
- Stein Olav Kvaløy Prosjektleder
- Cecilie E. Kiserud Postdoktorstipendiat (finansiert av denne bevilgning)
- Jon Håvard Loge Prosjektdeltaker
- Mette Seland Prosjektdeltaker
- Martin Maisenhölder Prosjektdeltaker
eRapport er utarbeidet av Sølvi Lerfald og Reidar Thorstensen, Regionalt kompetansesenter for klinisk forskning, Helse Vest RHF, og videreutvikles av de fire RHF-ene i fellesskap, med støtte fra Helse Vest IKT
Alle henvendelser rettes til eRapport